Billaud E - Search Results

1

Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV-infected adults on a long-term non-nucleoside reverse transcriptase inhibitor-based regimen.

Allavena C, Rodallec A, Sécher S, Reliquet V, Baffoin S, André-Garnier E, Billaud E, Raffi F, Ferré V. Allavena C, et al. Among authors: billaud e. J Med Virol. 2013 Nov;85(11):1878-82. doi: 10.1002/jmv.23679. Epub 2013 Jul 16. J Med Virol. 2013. PMID: 23861166

2

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors.

Dailly E, Billaud E, Reliquet V, Breurec S, Perré P, Léautez S, Jolliet P, Bourin M, Raffi F. Dailly E, et al. Among authors: billaud e. Eur J Clin Pharmacol. 2004 Jul;60(5):343-8. doi: 10.1007/s00228-004-0769-5. Epub 2004 May 20. Eur J Clin Pharmacol. 2004. PMID: 15156302

3

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.

Grabar S, Lanoy E, Allavena C, Mary-Krause M, Bentata M, Fischer P, Mahamat A, Rabaud C, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV. Grabar S, et al. HIV Med. 2008 Apr;9(4):246-56. doi: 10.1111/j.1468-1293.2008.00554.x. HIV Med. 2008. PMID: 18366449 Free article.

4

Impact of education and support on the tolerability and quality of life in a cohort of HIV-1 infected patients treated with enfuvirtide (SURCOUF Study).

Allavena C, Prazuck T, Reliquet V, Verdon R, Perré P, Le Moal G, Billaud E, Raffi F. Allavena C, et al. Among authors: billaud e. J Int Assoc Physicians AIDS Care (Chic). 2008 Jul-Aug;7(4):187-92. doi: 10.1177/1545109708322015. Epub 2008 Jul 3. J Int Assoc Physicians AIDS Care (Chic). 2008. PMID: 18599881

5

Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.

Fontas E, Kousignian I, Pradier C, Duvivier C, Poizot-Martin I, Durier C, Jarrousse B, Weiss L, Levy Y, Costagliola D; FHDH ANRS CO4 ANRS CO141. Fontas E, et al. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):206-14. doi: 10.1097/QAI.0b013e318190018c. J Acquir Immune Defic Syndr. 2009. PMID: 19131886

6

The immune response to the RT181-189 epitope in HIV-1-infected patients is associated with viral sequence polymorphism flanking the epitope.

Pacheco Y, Allavena C, Guilloux Y, Mueller-Schmucker SM, Hueckelhoven AG, André-Garnier E, Cleon F, Ferré V, Rodallec A, Billaud E, Harrer T, Raffi F, McIlroy D. Pacheco Y, et al. Among authors: billaud e. J Clin Immunol. 2011 Aug;31(4):681-9. doi: 10.1007/s10875-011-9520-z. Epub 2011 Apr 14. J Clin Immunol. 2011. PMID: 21491096

7

Virological response to darunavir in patients infected with HIV is linked to darunavir resistance-associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharmacological parameters.

Dailly E, Rodallec A, Allavena C, Deslandes G, Garnier E, Billaud E, Ferré V, Reliquet V, Bouquié R, Raffi F, Jolliet P. Dailly E, et al. Among authors: billaud e. Fundam Clin Pharmacol. 2012 Aug;26(4):538-42. doi: 10.1111/j.1472-8206.2011.00949.x. Epub 2011 May 5. Fundam Clin Pharmacol. 2012. PMID: 21545648

8

Risk factors of chronic kidney disease in HIV-infected patients.

Flandre P, Pugliese P, Cuzin L, Bagnis CI, Tack I, Cabié A, Poizot-Martin I, Katlama C, Brunet-François C, Yazdanpanah Y, Dellamonica P; New AIDS Data group. Flandre P, et al. Clin J Am Soc Nephrol. 2011 Jul;6(7):1700-7. doi: 10.2215/CJN.09191010. Epub 2011 May 12. Clin J Am Soc Nephrol. 2011. PMID: 21566114

9

Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.

Pacheco Y, Solé V, Billaud E, Allavena C, Plet A, Ferré V, Garrigue-Antar L, Raffi F, Jacques Y, McIlroy D. Pacheco Y, et al. Among authors: billaud e. AIDS. 2011 Sep 10;25(14):1701-10. doi: 10.1097/QAD.0b013e328349a437. AIDS. 2011. PMID: 21673554

10

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.

Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Goujard C, Meyer L; ANRS PRIMO and COPANA Cohorts. Krastinova E, et al. PLoS One. 2013 Aug 1;8(8):e71473. doi: 10.1371/journal.pone.0071473. Print 2013. PLoS One. 2013. PMID: 23936509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters